PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED

This adverse event was reported 593 times

These drugs are most commonly taken by patients reporting PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED:

# Drug Count
0 ROMIDEPSIN 118
1 CYCLOPHOSPHAMIDE 103
2 CYCLOPHOSPHAMIDE FOR INJECTION 103
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 103
4 BRENTUXIMAB VEDOTIN 92
5 PREDNISONE 82
6 DOXORUBICIN 80
7 METHOTREXATE SODIUM 65
8 METHOTREXATE 55
9 PREDNISOLONE 53
See all common drugs associated with PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 118 0.0699
1 PRALATREXATE 7 0.0108
2 BRENTUXIMAB VEDOTIN 92 0.0088
3 LISOCABTAGENE MARALEUCEL 5 0.0057
4 CILTACABTAGENE AUTOLEUCEL 16 0.0024
5 DICLOXACILLIN SODIUM 2 0.0022
6 EPCORITAMAB-BYSP 2 0.0015
7 BENDAMUSTINE HCL 19 0.0012
8 DACARBAZINE 9 0.0012
9 BLEOMYCIN SULFATE 12 0.0012
See all drugs enriched for association with PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED